Search results
Results From The WOW.Com Content Network
The most effective treatment is weight loss, but this may require bariatric surgery to achieve. [3] Weight loss of 25 to 30% is usually required to resolve the disorder. [3] The other first-line treatment is non-invasive positive airway pressure (PAP), usually in the form of continuous positive airway pressure (CPAP) at night.
Symptoms of hypoventilation and breathing malfunctions typically present after the rapid weight gain. Some patients may initially develop obstructive sleep apnea, which is common in obese children. [3] Obstructive sleep apnea is the most common form of sleep apnea, and causes breathing to abruptly stop and begin again during sleep.
783 Symptoms concerning nutrition, metabolism and development. 783.0 Anorexia. Loss of appetite; 783.1 Abnormal weight gain; 783.2 Abnormal loss of weight; 783.3 Feeding difficulties and mismanagement; 783.4 Lack of expected normal physiological development; 783.5 Polydipsia; 783.6 Polyphagia; 783.9 Other; 784 Symptoms involving head and neck ...
Risk Factors for Sleep Apnea. There are several risk factors for sleep apnea. These include: Obesity. If you have excess weight or obesity, you may have more fat deposits in your neck that can put ...
The terms obstructive sleep apnea syndrome (OSAS) or obstructive sleep apnea–hypopnea syndrome (OSAHS) may be used to refer to OSA when it is associated with symptoms during the daytime (e.g. excessive daytime sleepiness, decreased cognitive function).
Sleep apnea is measured by the apnea-hypopnea index (AHI). An AHI is determined with a sleep study. AHI values for adults are categorized as: [2] [3] Normal: AHI<5; Mild sleep apnea: 5≤AHI<15; Moderate sleep apnea: 15≤AHI<30; Severe sleep apnea: AHI≥30; An episode is when a person hesitates to breathe or stops their breathing altogether.
The typical screening process for sleep apnea involves asking patients about common symptoms such as snoring, witnessed pauses in breathing during sleep and excessive daytime sleepiness. [19] There is a wide range in presenting symptoms in patients with sleep apnea, from being asymptomatic to falling asleep while driving. [19]
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.